在非传染性尿道炎的治疗里图西马布:一篇评论
1Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, People's Republic of China.
Journal of inflammation research
|October 4, 2024
概括
利图西马布 (RTX) 有效治疗对其他疗法无反应的非传染性脑膜炎 (NIU). 这项研究表明,RTX可以改善视力,并减少大多数患者的炎症,为这种危及视力的疾病提供了新的治疗选择.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 非传染性脑膜炎 (NIU) 是一种严重的免疫媒介眼睛疾病,导致视力丧失.
- 由于对皮质类固醇和免疫疗法的耐药性,NIU的管理具有挑战性.
- 现有的治疗方法往往失败,需要替代治疗策略.
研究的目的:
- 评估Rituximab (RTX) 治疗非传染性脑膜炎 (NIU) 的疗效和安全性.
- 评估RTX作为NIU患者的治疗选择,这些患者对传统疗法不耐药.
主要方法:
- 个人病例报告和78名接受RTX治疗的NIU患者的小规模研究的综述.
- 分析患者人口统计,相关的并发症 (例如,青少年异常性关节炎),脑膜炎亚型和先前的治疗方法.
- 视力敏度,眼部炎症,皮质类固醇剂量和RTX开始后整体治疗反应的评估.
主要成果:
- 88.6%的患者对RTX.表现出积极的反应.
- 79.5%的眼睛炎症得到解决,44.2%的视力敏度得到改善.
- 81.1%的患者能够减少他们的皮质类固醇剂量,表明疾病控制得到改善.
结论:
- 利图西马布 (RTX) 是一种有效的治疗非传染性脑膜炎 (NIU) 耐药的类固醇和多种免疫疗法.
- 在NIU患者中,RTX在改善视觉结果和减少炎症方面具有显著的潜力.
- 在特定的NIU病例中,考虑RTX作为潜在的第一线治疗是合理的.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489